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BMI

:   body mass index

CI

:   confidence interval

EDD

:   estimated delivery date

GA

:   gestational age

LMP

:   last menstrual period

OR

:   odds ratio

US

:   ultrasound

Key MessageVariance in early fetal growth can bias ultrasound‐based pregnancy dating. Maternal obesity, height, and fetal sex may partly explain large discrepancies between pregnancy‐dating methods.

Introduction {#aogs13034-sec-0006}
============

The method of estimating gestational age (GA) by ultrasound (US), using fetal size as a proxy for age, is usually more precise than the method based on the last menstrual period (LMP). However, there is variance in early growth, which may affect the reliability of the US‐based estimate that is used for clinical decision‐making [1](#aogs13034-bib-0001){ref-type="ref"}, [2](#aogs13034-bib-0002){ref-type="ref"}. For example, early discrepancies between expected and actual fetal size can be detected in assisted reproductive technology pregnancies and are associated with maternal obesity and the birth of small‐for‐gestational‐age infants [1](#aogs13034-bib-0001){ref-type="ref"}. In addition, fetal sex, by association with size, affects the accuracy of US pregnancy dating. Male fetuses have on average a 1‐mm larger biparietal diameter early in the second trimester, corresponding to about one day in growth [2](#aogs13034-bib-0002){ref-type="ref"}.

Average differences between LMP‐ and US‐based estimated delivery dates (EDD) are small, with LMP estimates of one to three days more advanced pregnancy length than US estimates [3](#aogs13034-bib-0003){ref-type="ref"}. Nevertheless, the choice of method affects the rates of preterm and post‐term deliveries, as well as neonatal outcomes, which is probably related to correction of EDD in pregnancies with large discrepancies between dating methods [4](#aogs13034-bib-0004){ref-type="ref"}, [5](#aogs13034-bib-0005){ref-type="ref"}.

Maternal and fetal characteristics associated with discrepancies between EDD‐LMP and EDD‐US estimates include maternal age, parity, smoking, obesity, diabetes, maternal height, educational level, fetal sex, malformations, and small‐for‐gestational‐age infants [1](#aogs13034-bib-0001){ref-type="ref"}, [6](#aogs13034-bib-0006){ref-type="ref"}, [7](#aogs13034-bib-0007){ref-type="ref"}, [8](#aogs13034-bib-0008){ref-type="ref"}, [9](#aogs13034-bib-0009){ref-type="ref"}. Large discrepancies between methods have clinical implications through association with adverse outcomes [6](#aogs13034-bib-0006){ref-type="ref"}, [10](#aogs13034-bib-0010){ref-type="ref"}.

Because mean differences in early fetal growth are small, and adverse outcomes are thought to occur predominantly in pregnancies with a large deviation from average growth, the aim of this study was to identify characteristics, present at the time of pregnancy dating, associated with large discrepancies between EDD‐LMP and EDD‐US in a population‐based sample of Swedish pregnancies.

Material and methods {#aogs13034-sec-0007}
====================

Data were obtained from the Swedish Medical Birth Register and the Swedish Patient Register. We included all singleton births in Sweden from 1995 to 2010, with valid documentation of EDD based on both LMP and US. To avoid data entry errors, and larger discrepancies because of reasons other than variation in early growth, pregnancies with discrepancies \>20 days were excluded. The Medical Birth Register contains information on more than 99% of all births in Sweden since 1973, including maternal sociodemographic characteristics and prospectively collected information during pregnancy, delivery, and the neonatal period [11](#aogs13034-bib-0011){ref-type="ref"}. The register has been found reliable for research purposes, with good internal validity [12](#aogs13034-bib-0012){ref-type="ref"}. Since 1990, US scanning has been offered to all pregnant women with more than 95% acceptance. Since 1995, nearly all clinics have used EDD‐US [11](#aogs13034-bib-0011){ref-type="ref"}.

Variables from the Medical Birth Register included maternal age, parity, height, weight, smoking and snuff (smokeless tobacco) use at first antenatal visit, family situation, occupational status, LMP, EDD‐LMP, EDD‐US, and infant sex (Table [1](#aogs13034-tbl-0001){ref-type="table-wrap"}).

###### 

Correlates of large discrepancies between pregnancy dating methods. Odds ratios (OR) with 95% confidence intervals (95% CI) for large negative discrepancy (below the 10th percentile in the discrepancy distribution; −9 to −20 days) and large positive discrepancy (above the 90th percentile in the discrepancy distribution; +4 to +20 days) between EDD‐LMP and EDD‐US[a](#aogs13034-note-0002){ref-type="fn"} in association with maternal characteristics at the first antenatal visit, fetal sex, and maternal medical history variables

                                                                                       Large negative discrepancies   Large positive discrepancies                                                                                                  
  ------------------------------------------------------------------------------------ ------------------------------ ------------------------------ ----- ------ ------------ ------ ------------ --------- ----- ----- ------ ------------ ------ ------------
  Age at delivery (years)                                                                                                                                                                                                                           
  \<20                                                                                 18 662                         5                              3     1.84   1.78--1.90   1.79   1.71--1.86   15 712    3     3     1.14   1.09--1.19   1.05   1.00--1.11
  20--24                                                                               109 111                        24                             16    1.42   1.40--1.44   1.40   1.37--1.43   96 840    14    16    1.00   0.98--1.03   1.00   0.97--1.02
  25--29                                                                               226 304                        38                             35    1.00   --           1.00   --           217 512   32    35    1.00   --           1.00   --
  30--34                                                                               198 848                        25                             33    0.71   0.69--0.72   0.68   0.67--0.70   206 725   33    33    1.11   1.09--1.13   1.12   1.10--1.14
  35--39                                                                               73 707                         7                              13    0.54   0.53--0.56   0.49   0.48--0.50   81 893    15    13    1.30   1.28--1.33   1.29   1.26--1.32
  \>40                                                                                 10 300                         1                              2     0.46   0.43--0.49   0.38   0.35--0.40   12 211    3     2     1.60   1.53--1.67   1.57   1.50--1.65
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Height (cm)                                                                                                                                                                                                                                       
  \<160                                                                                119 842                        22                             18    1.22   1.21--1.24   1.17   1.15--1.20   113 261   17    18    0.98   0.96--1.00   0.96   0.94--0.98
  160--172[f](#aogs13034-note-0007){ref-type="fn"}                                     412 279                        64                             65    1.00   --           1.00   --           407 312   63    65    1.00   --           1.00   --
  \>172                                                                                104 811                        14                             17    0.82   0.81--0.84   0.86   0.84--0.88   110 320   20    17    1.17   1.15--1.19   1.19   1.17--1.21
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  BMI classes according to WHO classification                                                                                                                                                                                                       
  Underweight                                                                          15 836                         3                              2     1.36   1.31--1.42   1.18   1.13--1.24   15 049    3     2     1.03   0.98--1.07   1.03   0.98--1.09
  Normal range                                                                         402 285                        60                             64    1.00   --           1.00   --           404 877   65    64    1.00   --           1.00   --
  Pre‐obese                                                                            153 378                        24                             24    1.08   1.06--1.09   1.07   1.05--1.08   151 804   24    24    0.98   0.97--1.00   0.97   0.95--0.98
  Obese class I                                                                        47 165                         9                              7     1.39   1.36--1.42   1.34   1.30--1.37   43 689    7     7     0.91   0.89--0.94   0.90   0.87--0.92
  Obese class II                                                                       13 860                         3                              2     1.74   1.68--1.81   1.70   1.63--1.78   11 950    2     2     0.83   0.79--0.87   0.80   0.76--0.85
  Obese class III                                                                      4408                           1                              1     2.18   2.05--2.33   2.16   2.01--2.33   3524      1     1     0.78   0.71--0.86   0.74   0.66--0.82
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Living with partner                                                                                                                                                                                                                               
  Yes                                                                                  599 095                        93                             94    1.00   --           1.00   --           593 478   93    94    1.00   --           1.00   --
  No                                                                                   30 259                         6                              5     1.23   1.20--1.27   0.99   0.95--1.02   30 030    6     5     1.25   1.22--1.29   1.21   1.17--1.25
  Missing                                                                              7578                           1                              1                                             7385      1     1                                
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Employed                                                                                                                                                                                                                                          
  Yes                                                                                  461 462                        68                             74    1.00   --           1.00   --           461 500   71    74    1.00   --           1.00   --
  No                                                                                   113 304                        21                             17    1.32   1.30--1.34   1.09   1.07--1.11   109 636   19    17    1.12   1.10--1.14   1.16   1.14--1.19
  Missing                                                                              62 166                         12                             9                                             59 757    10    9                                
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Smoking at first antenatal visit                                                                                                                                                                                                                  
  No                                                                                   568 365                        87                             90    1.00   --           1.00   --           565 880   89    90    1.00   --           1.00   --
  Yes                                                                                  59 502                         12                             9     1.35   1.33--1.38   1.13   1.11--1.16   56 077    9     9     1.04   1.02--1.07   1.04   1.02--1.07
  Missing                                                                              9065                           2                              1                                             8936      1     1                                
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Snuff use at first antenatal visit[g](#aogs13034-note-0008){ref-type="fn"}                                                                                                                                                                        
  No                                                                                   483 073                        73                             77    1.00   --           1.00   --           481 672   75    77    1.00   --           1.00   --
  Yes                                                                                  5844                           1                              1     1.16   1.09--1.24   1.12   1.05--1.20   5670      1     1     1.01   0.94--1.08   1.01   0.94--1.09
  Missing                                                                              148 015                        26                             23                                            143 551   24    23                               
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Parity                                                                                                                                                                                                                                            
  0‐parous                                                                             280 971                        45                             44    1.00   --           1.00   --           276 029   43    44    1.00   --           1.00   --
  1‐parous                                                                             236 861                        36                             38    0.92   0.91--0.93   1.05   1.03--1.07   233 995   35    38    0.94   0.93--0.96   0.91   0.89--0.92
  2‐parous                                                                             85 121                         13                             13    0.94   0.92--0.95   1.20   1.17--1.24   86 219    15    13    1.10   1.08--1.12   1.02   0.99--1.04
  3‐parous                                                                             22 807                         4                              4     1.04   1.00--1.07   1.40   1.34--1.46   23 246    4     4     1.25   1.21--1.29   1.13   1.08--1.17
  4‐parous or more                                                                     11 172                         2                              2     1.24   1.19--1.30   1.77   1.67--1.87   11 404    3     2     1.49   1.43--1.56   1.29   1.23--1.37
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Fetal sex                                                                                                                                                                                                                                         
  Male                                                                                 319 057                        44                             52    1.00   --           1.00   --           340 140   65    52    1.76   1.74--1.78   1.80   1.77--1.83
  Female                                                                               317 875                        56                             49    1.34   1.33--1.36   1.36   1.34--1.38   290 753   35    49    1.00   --           1.00   --
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Medical history variables[h](#aogs13034-note-0009){ref-type="fn"}                                                                                                                                                                                 
  Diabetes mellitus                                                                                                                                                                                                                                 
  No                                                                                   635 613                        100                            100   1.00   --           1.00   --           629 860   100   100   1.00   --           1.00   --
  Yes                                                                                  1319                           0                              0     2.15   1.91--2.41   1.95   1.69--2.25   1033      0     0     0.78   0.65--0.92   0.86   0.70--1.04
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Gestational diabetes in a former pregnancy[i](#aogs13034-note-0010){ref-type="fn"}                                                                                                                                                                
  No                                                                                   353 236                        99                             99    1.00   --           1.00   --           353 236   99    100   1.00   --           1.00   --
  Yes                                                                                  2725                           1                              1     1.61   1.48--1.75   1.47   1.38--1.63   2725      1     0     0.75   0.67--0.85   0.74   0.65--0.84
  Total                                                                                355 961                        100                            100                                           355 961   100   100                              
  Hypertensive disorders                                                                                                                                                                                                                            
  No                                                                                   636 565                        100                            100   1.00   --           1.00   --           630 560   100   100   1.00   --           1.00   --
  Yes                                                                                  367                            0                              0     1.37   1.08--1.74   1.26   0.94--1.68   333       0     0     0.88   0.66--1.18   0.76   0.54--1.07
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Preeclampsia in a former pregnancy[i](#aogs13034-note-0010){ref-type="fn"}                                                                                                                                                                        
  No                                                                                   345 235                        96                             97    1.00   --           1.00   --           345 235   98    97    1.00   --           1.00   --
  Yes                                                                                  10 726                         4                              3     1.22   1.17--1.28   1.16   1.09--1.23   10 726    2     3     0.86   0.82--0.91   0.92   0.86--0.98
  Total                                                                                355 961                        100                            100                                           355 961   100   100                              
  Hypothyroidism                                                                                                                                                                                                                                    
  No                                                                                   635 635                        100                            100   1.00   --           1.00   --           629 595   100   100   1.00   --           1.00   --
  Yes                                                                                  1297                           0                              0     0.91   0.78--1.05   0.97   0.82--1.14   1298      0     0     0.96   0.83--1.11   0.85   0.72--1.01
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Systematic lupus erythematosus                                                                                                                                                                                                                    
  No                                                                                   636 720                        100                            100   1.00   --           1.00   --           630 695   100   100   1.00   --           1.00   --
  Yes                                                                                  212                            0                              0     1.17   0.84--1.63   1.24   0.83--1.84   198       0     0     0.85   0.58--1.25   0.79   0.50--1.24
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Ulcerative colitis                                                                                                                                                                                                                                
  No                                                                                   636 163                        100                            100   1.00   --           1.00   --           630 101   100   100   1.00   --           1.00   --
  Yes                                                                                  769                            0                              0     0.76   0.62--0.92   0.82   0.64--1.04   792       0     0     0.96   0.80--1.15   1.09   0.89--1.34
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Crohn\'s disease                                                                                                                                                                                                                                  
  No                                                                                   636 174                        100                            100   1.00   --           1.00   --           630 124   100   100   1.00   --           1.00   --
  Yes                                                                                  758                            0                              0     0.92   0.77--1.11   0.92   0.73--1.14   769       0     0     1.05   0.88--1.26   1.17   0.96--1.44
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Depressive disorders                                                                                                                                                                                                                              
  No                                                                                   634 329                        100                            100   1.00   --           1.00   --           628 468   100   100   1.00   --           1.00   --
  Yes                                                                                  2603                           1                              0     1.26   1.15--1.38   1.09   0.98--1.21   2425      0     0     0.92   0.83--1.03   0.91   0.81--1.03
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              
  Anxiety disorders and phobias                                                                                                                                                                                                                     
  No                                                                                   635 326                        100                            100   1.00   --           1.00   --           629 406   100   100   1.00   --           1.00   --
  Yes                                                                                  1606                           0                              0     1.30   1.16--1.47   1.14   1.00--1.30   1487      0     0     0.93   0.81--1.07   0.92   0.79--1.07
  Total                                                                                636 932                        100                            100                                           630 893   100   100                              

Estimated due date based on the date of the last menstrual period (EDD‐LMP) and estimated due date based ultrasound biometry (EDD‐US).

Pregnancies with negative discrepancy below the 10th percentile (−9 to −20 days), *n* = 119 275 births.

Reference category is median discrepancy ±2 days (−1 to +3 days), *n* = 517 657 births.

Pregnancies with positive discrepancy above the 90th percentile (+4 to +20 days), *n* = 113 236 births.

Adjusted, as appropriate, for age, parity, height, BMI, smoking at first antenatal visit, and employment status.

Mean ± 1 SD.

Variable available for analyses for births in years 2000--2010.

Inpatient diagnoses registered at least once from 5 years to 9 months before registered birth.

Analyses excluding 0‐parous women.

\[Correction added on 23 December 2016 after online publication: In Table 1, the values of Male and Female Fetal Sex under Large positive discrepancies have been corrected.\]
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Maternal height was defined as shorter stature if height was below 1 standard deviation (SD) from the mean, and taller stature was defined as above 1 SD from the mean. Maternal body mass index (BMI) was calculated based on height and weight, and categorized according to the World Health Organization classification as underweight \<18.5 kg/m^2^, normal weight 18.5--24.9 kg/m^2^, pre‐obesity 25.0--29.9 kg/m^2^, obesity class I (30.0--34.9 kg/m^2^), obesity class II (35.0--39.9 kg/m^2^), and obesity class III (\>40 kg/m^2^) [13](#aogs13034-bib-0013){ref-type="ref"}.

Information on maternal diagnoses, from five years before until nine months (EDD‐US minus 280 days) before delivery, was collected from the Swedish Patient Register. In the inpatient setting, diagnoses were included if they appeared once. In the outpatient setting, diagnoses would have to be registered twice to avoid any preliminary diagnoses. Inpatient diagnoses were retrieved for the whole study period, and outpatient diagnoses were retrieved from 2001. Diagnoses that theoretically could affect early fetal growth were chosen, and included diabetes, gestational diabetes in a former pregnancy, hypertensive disorders, preeclampsia in a former pregnancy, hypothyroidism, systemic lupus erythematosus, inflammatory bowel disease (Crohn\'s disease and ulcerative colitis), depressive‐affective disorders, and phobias and anxiety disorders.

Discrepancy was defined as EDD‐LMP minus EDD‐US, corresponding to the difference in days between the two pregnancy‐dating methods as recorded in the Medical Birth Register. *Negative discrepancy* corresponds to EDD‐LMP earlier than EDD‐US, reflecting a more advanced GA by LMP estimation than by US estimation, i.e. the fetus was smaller than expected when dated by US and EDD was postponed. *Positive discrepancy* was defined as EDD‐LMP later than EDD‐US, corresponding to a less advanced GA by LMP‐estimation than the GA estimated by US‐examination, i.e. the fetus was larger than expected when dated by US and EDD was moved to an earlier date.

Discrepancies of interest were defined as those below the 10th percentile (large negative discrepancy) and above the 90th percentile (large positive discrepancy) in the discrepancy distribution, and the reference category was defined as discrepancies within 2 days of the median. Remaining pregnancies, not corresponding to the large discrepancy categories or the reference category, were excluded from further analyses. Analyses were conducted with the purpose of assessing to what extent maternal characteristics, disease, and fetal sex were associated with large discrepancies in days between EDD‐LMP and EDD‐US. Multiple logistic regression analyses were used to calculate odds ratios (OR) and 95% confidence intervals (95% CI) for large positive or negative discrepancy, in association with maternal characteristics, disease, and fetal sex.

Analyses were restricted to births with maternal height 140--189 cm and maternal weight 35--139 kg, to reduce data entry errors. Analyses of diagnoses in former pregnancies were restricted to parous women. All models were adjusted for age, parity, height, BMI, smoking in early pregnancy, and employment status, as appropriate. Analyses were further adjusted for maternal comorbidity, which was a composite variable defined as the woman having one of the selected diagnoses recorded at least once. Statistical analyses were conducted using the statistical software R version 3.1.3, R Core Team (2015).

The Regional Ethical Review Board in Uppsala, Sweden, approved the study protocol reference number 2012/412, 19 December 2012.

Results {#aogs13034-sec-0008}
=======

The total number of births in the study population was 1 201 679. Mean maternal age was 30 years (SD = 5 years), mean height was 166 cm (SD = 6 cm), and mean BMI was 24 kg/m^2^ (SD = 4 kg/m^2^). Most commonly, there was no (16%) or only a few days\' discrepancy between EDD‐LMP and EDD‐US (Figure [1](#aogs13034-fig-0001){ref-type="fig"}). Mean discrepancy was +2 days, and the median discrepancy was +1 day. A large negative discrepancy, below the 10th percentile, corresponded to −9 to −20 days, whereas a large positive discrepancy, above the 90th percentile, corresponded to +4 to +20 days. Information on maternal height or weight was missing in 101 630 births (8.5%). A total of 1 100 049 births had valid documentation for maternal height and weight: large negative discrepancies (*n* = 119 275), reference category (discrepancy −1 to +3 days, *n* = 517 657), and large positive discrepancies (*n* = 113 236).

![Number of births and discrepancy in days between ultrasound (US)‐based and last menstrual period (LMP)‐based estimated delivery date (EDD).](AOGS-96-86-g001){#aogs13034-fig-0001}

For large negative discrepancies, the strongest association was observed for obesity class III (OR 2.16, 95% CI 2.01--2.33). Other factors associated with large negative discrepancies were: diabetes (OR 1.95, 95% CI 1.69--2.25), maternal age \<20 years (OR 1.79, 95% CI 1.71--1.86), being four‐parous or more (OR 1.77, 95% CI 1.67--1.87), and obesity class II, a history of gestational diabetes, age 20--24 years, three‐parous, female fetus, obesity class I, underweight, shorter stature, a history of preeclampsia, smoking, snuff use, unemployment, pre‐obesity, or primiparity (Table [1](#aogs13034-tbl-0001){ref-type="table-wrap"}). Women who had a taller stature or were aged 30 years or above were less likely to have large negative discrepancies.

For large positive discrepancies, the strongest association was observed for pregnancies with a male fetus (OR 1.80, 95% CI 1.77--1.83). Other factors associated with large positive discrepancies were: age 40 years or above (OR 1.57, 95% CI 1.50--1.65), 35--39 years (OR 1.29, 95% CI 1.26--1.32), being four‐parous or more (OR 1.29, 95% CI 1.23--1.37), not living with a partner, taller stature, unemployed, being three‐parous, 30--34 years, or smoking (Table [1](#aogs13034-tbl-0001){ref-type="table-wrap"}). Women who were overweight, obese, had gestational diabetes or preeclampsia, were primiparous, or had a shorter stature were less likely to have large positive discrepancies.

When outpatient diagnoses were included in the adjusted analyses, possible for the years 2006--2010, there were higher odds for large negative discrepancies in association with depressive disorder OR 1.11 (95% CI 1.02--1.21) and higher odds for large positive discrepancies with Crohn\'s disease (OR 1.36, 95% CI 1.10--1.67). There were lower odds for large positive discrepancies with diabetes (OR 0.79, 95% CI 0.66--0.94), hypothyroid disease (OR 0.85, 95% CI 0.73--0.99), and depressive disorders (OR 0.85, 95% CI 0.78--0.94). Adjusting for maternal co‐morbidity only marginally affected the estimates.

Discussion {#aogs13034-sec-0009}
==========

This study confirmed previously reported associations of discrepancies between pregnancy‐dating methods and characteristics such as obesity, maternal age, parity, fetal sex, maternal height, smoking, and diabetes [6](#aogs13034-bib-0006){ref-type="ref"}, [8](#aogs13034-bib-0008){ref-type="ref"}, [9](#aogs13034-bib-0009){ref-type="ref"}. Our study population was partly overlapping with the populations in two of the studies [8](#aogs13034-bib-0008){ref-type="ref"}, [9](#aogs13034-bib-0009){ref-type="ref"}. However, we included a more recent and longer time period and also assessed other possible risk factors for discrepancies in dating methods, such as snuff use, unemployment, living without a partner, and preeclampsia in a former pregnancy.

Discrepancies could be the result of variation in menstrual cycles or difficulties recalling the LMP, as well as differences in early fetal growth and technical issues in US biometry [1](#aogs13034-bib-0001){ref-type="ref"}, [2](#aogs13034-bib-0002){ref-type="ref"}. In most situations, it may be difficult to determine which of the estimates is biased. However, the systematic effect of both fetal sex, attributable to the smaller size of female fetuses, and maternal height, because of genetic influence on fetal growth, is not likely to be explained by unreliable LMP.

Only small average discrepancies between LMP‐based and US‐based methods are expected because both methods predict EDD relatively well; US is the preferred method, being more precise in the general population [14](#aogs13034-bib-0014){ref-type="ref"}. However, as average differences may not be clinically meaningful, we compared pregnancies where a substantial difference was observed to those with minimal differences. In this study, discrepancies exceeded one week in more than one of six pregnancies (14% with negative and 4% with positive discrepancies). In addition, large negative discrepancies were associated with obesity and diabetes. These conditions, as well as large negative discrepancies between pregnancy‐dating methods, have been associated with adverse outcomes [1](#aogs13034-bib-0001){ref-type="ref"}, [6](#aogs13034-bib-0006){ref-type="ref"}, [10](#aogs13034-bib-0010){ref-type="ref"}, [15](#aogs13034-bib-0015){ref-type="ref"}, [16](#aogs13034-bib-0016){ref-type="ref"}. The reason for the association between large negative discrepancies between the dating methods and adverse outcomes may be misclassifications of GA, resulting for example in delayed post‐term inductions [6](#aogs13034-bib-0006){ref-type="ref"}, [10](#aogs13034-bib-0010){ref-type="ref"}. Another reason is that a smaller‐than‐expected fetus at the time of US pregnancy dating may be growth‐restricted [1](#aogs13034-bib-0001){ref-type="ref"}, [10](#aogs13034-bib-0010){ref-type="ref"}.

Maternal age \>30 years was associated with larger fetuses than expected at the US scan, and a similar effect of maternal age has been reported earlier [6](#aogs13034-bib-0006){ref-type="ref"}. This is consistent with another study relating maternal age to increasing embryonic growth trajectories [17](#aogs13034-bib-0017){ref-type="ref"}. However, the follicular phase can be one day shorter in women from 35 years of age, which could increase the probability of earlier conception and a large‐than‐expected fetus at the US scan [18](#aogs13034-bib-0018){ref-type="ref"}. Tunón et al. found that maternal age affected the precision of EDD‐US estimates but not of EDD‐LMP estimates, indicating an effect on fetal growth [19](#aogs13034-bib-0019){ref-type="ref"}. Age below 25 years was associated with higher odds for both negative and positive large discrepancies, hypothetically because of greater LMP uncertainty.

Maternal height systematically affected the odds for large discrepancies; taller mothers were more likely to have larger fetuses and shorter mothers to have smaller fetuses than expected according to EDD‐LMP. The effect of height was expected, based on genetic influence rather than menstrual cycle differences [5](#aogs13034-bib-0005){ref-type="ref"}, [20](#aogs13034-bib-0020){ref-type="ref"}.

Obesity class III had the largest effect on large negative discrepancies. Every increase in BMI class above the normal range increased the odds for large negative discrepancies, and decreased the odds for large positive discrepancies. It could be hypothesized that obese women would have larger fetuses than expected at the US scan because of associated macrosomia. The association between high maternal BMI and negative discrepancies is, however, in accordance with results of earlier studies [6](#aogs13034-bib-0006){ref-type="ref"}, [9](#aogs13034-bib-0009){ref-type="ref"}. In particular, in another study based on data from the Swedish Medical Birth Register between 1992 and 2005, EDD was more often postponed among overweight and obese women [9](#aogs13034-bib-0009){ref-type="ref"}. One explanation could be prolonged menstruation cycles associated with obesity [21](#aogs13034-bib-0021){ref-type="ref"}, [22](#aogs13034-bib-0022){ref-type="ref"}. Other reasons might be due to the accuracy of the US measurements of fetal size when examining obese women, or a possible repressive influence of obesity on early fetal growth. According to a study on assisted reproductive technology pregnancies, there is a risk of underestimating the GA when it is based on US examination in obese women [1](#aogs13034-bib-0001){ref-type="ref"}. In Sweden, 13% of pregnant women in 2010 were obese [6](#aogs13034-bib-0006){ref-type="ref"}, [10](#aogs13034-bib-0010){ref-type="ref"}, [23](#aogs13034-bib-0023){ref-type="ref"}. Both maternal obesity and negative discrepancies are known to be associated with adverse pregnancy outcomes [6](#aogs13034-bib-0006){ref-type="ref"}, [10](#aogs13034-bib-0010){ref-type="ref"}. Underweight women were also at higher odds for large negative discrepancies, as expected based on a higher risk for small‐for‐gestational‐age infants and delayed ovulations [22](#aogs13034-bib-0022){ref-type="ref"}, [24](#aogs13034-bib-0024){ref-type="ref"}.

Of the socioeconomic factors that were assessed, living without a partner and being unemployed increased odds for both negative and positive discrepancies. However, the association between living without a partner and a negative discrepancy was not significant after adjustment. Even though Sweden offers free antenatal care for all pregnant women, and living without a partner is a socially accepted family structure, this group differs from the rest of the population in terms of risk for discrepancies for mostly unknown reasons.

Smoking and snuff tobacco use were associated with higher odds for large negative discrepancies. There is a well‐known repressive effect on fetal growth caused by smoking, with linear dose--response curves for increased smoking in relation to shorter biparietal diameter and femur length in the third trimester [25](#aogs13034-bib-0025){ref-type="ref"}. Our results suggested an effect of smoking also on early fetal growth, which was in line with another study, where fetal crown rump length was found to be shorter in women who smoked 10 or more cigarettes per day as compared with non‐smokers [26](#aogs13034-bib-0026){ref-type="ref"}.

Advanced parity increased the odds for large discrepancies. These results are in line with a previous Swedish study with data partly overlapping those included in this study [8](#aogs13034-bib-0008){ref-type="ref"}. The effect estimates in the current study remained significant for large negative discrepancies after adjustments; however, the associations with large positive discrepancies were weaker after adjustments, strengthening the notion of a more complex association.

Fetal sex had a systematic effect on discrepancies. The odds for large negative discrepancies were higher for female fetuses, whereas the odds for large positive discrepancies were higher for male fetuses. This could be attributed to the smaller average size of female fetuses in early pregnancy, and confirms results from earlier studies [2](#aogs13034-bib-0002){ref-type="ref"}, [8](#aogs13034-bib-0008){ref-type="ref"}, [27](#aogs13034-bib-0027){ref-type="ref"}. Although most fetuses are mildly misclassified, a number of fetuses are misclassified by more than a week because they are considerably larger (more often males) or smaller (more often females) than the mean. This is reflected in adversely affected odds for postmaturity‐related morbidity and mortality in post‐term female infants in a Swedish register study after introduction of -- predominantly second trimester -- US pregnancy dating, and also reflected in a successively increasing male‐to‐female birth ratio in gestational weeks 41, 42, and 43 [28](#aogs13034-bib-0028){ref-type="ref"}, [29](#aogs13034-bib-0029){ref-type="ref"}. According to a Norwegian study, this increased post‐term male--female ratio is normalized when estimates are based on LMP or first trimester instead of second trimester US [27](#aogs13034-bib-0027){ref-type="ref"}.

The association of maternal diabetes with negative discrepancies confirms the results of other studies [6](#aogs13034-bib-0006){ref-type="ref"}, [30](#aogs13034-bib-0030){ref-type="ref"}. In a Norwegian study, women with type 1 diabetes had negative discrepancies of seven or more days in 25% of pregnancies, and 14 or more days in 10% of pregnancies, compared with a certain LMP date, with a risk of going beyond the optimal pregnancy length because of systematic postponement of EDD‐US [30](#aogs13034-bib-0030){ref-type="ref"}.

Odds of negative discrepancies for those with a history of hypertensive disease were not significant after adjustments, which could indicate that the effect on fetal growth occurs later in pregnancy, although hypertension has also been associated with shorter crown rump length measurements [7](#aogs13034-bib-0007){ref-type="ref"}. A history of preeclampsia in former pregnancy was associated with higher odds for negative discrepancies and lower odds for positive discrepancies. This is in accordance with the higher risk among these women, also in the currently studied pregnancy, for preeclampsia and intrauterine growth retardation, which can be of early onset [31](#aogs13034-bib-0031){ref-type="ref"}.

A history of anxiety disorders was associated with higher odds for negative discrepancies. However, there were no statistically significant associations with large negative or large positive discrepancies when having a history of hypothyroidism, systemic lupus erythematosus, ulcerative colitis, Crohn\'s disease or depressive disorders, which could be the result of a later effect on growth.

The present large register‐based cohort, which could be considered population‐based as more than 99% of all births were registered, allowed for high external validity compared with an earlier hospital‐based study [6](#aogs13034-bib-0006){ref-type="ref"}. In comparison with two earlier Swedish register studies, the current study includes a larger sample, addresses a more recent time period and adds several other characteristics, such as maternal medical history variables (for example preeclampsia and diabetes in an former pregnancy), as well as snuff use, unemployment, and living without a partner [8](#aogs13034-bib-0008){ref-type="ref"}, [9](#aogs13034-bib-0009){ref-type="ref"}. Detailed information was prospectively recorded, minimizing recall bias. A limitation of the study was that no information of regularity on menstrual cycles was included in the register. There was also some missing information on maternal weight, possibly introducing a degree of inclusion bias.

Large discrepancies between the LMP and US methods are not rare, and clinicians should be aware that one or both methods may be unreliable. This is particularly important in the extremes of pregnancy length, when GA influences clinical decision‐making. Early pregnancy dating is preferred -- due to increasing growth variance with advancing GA -- and is optimally performed at 10 weeks + 0 days to 13 weeks + 6 days according to the recommendations of the International Society of Ultrasound in Obstetrics and Gynecology [32](#aogs13034-bib-0032){ref-type="ref"}.

Increased awareness of maternal and fetal characteristics that can bias GA estimates can be helpful in clinical situations when large discrepancies between methods are noted. A large discrepancy combined with characteristics affecting early growth should lead to critical evaluation of the GA estimate based on US, and additional information, such as the date of the LMP or an assumed date of conception, should be considered before decision‐making. As large negative discrepancies are associated with adverse outcomes, these pregnancies may benefit from closer monitoring in order to detect intrauterine growth retardation and to avoid post‐term pregnancies [14](#aogs13034-bib-0014){ref-type="ref"}, [33](#aogs13034-bib-0033){ref-type="ref"}.

Conclusions {#aogs13034-sec-0010}
===========

Maternal and fetal characteristics affect discrepancies between pregnancy‐dating methods based on LMP and US. The US estimate is often regarded as the most reliable method and is used for clinical decision‐making. This study indicates that the precision of the US estimate is systematically affected by characteristics such as maternal height and fetal sex, and possibly partly by obesity. In clinical settings, large discrepancies between GA estimates, in combination with certain maternal or fetal characteristics, can help clinicians identify pregnancies with high risk for uncertain dating estimates in order to make appropriate management decisions.

Funding {#aogs13034-sec-0012}
=======

This study was supported by Uppsala University Hospital, Center for Clinical Research, Västerås, Uppsala University, Karolinska Institutet and the County Council of Västmanland, Sweden.

Bengt Haglund contributed to the study design and gave valuable advice on the analyses, interpretation, and presentation of data. Per Wikman contributed to the statistical analyses.
